Accordingly, the reduction in Tyr phosphorylation levels in AD neurons after Tyr kinase inhibitor exposure (Sunitinib and PP2) resulted in a decrease of Tyr phosphorylation of both APP and Fyn and rescued the APP binding to Clathrin and AP2. Here, FYN is linked to Alzheimer disease.